Liselotte Hyveled's most recent trade in TriSalus Life Sciences Inc was a trade of 10,040 Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | Liselotte Hyveled | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 10,040 | 10,040 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Liselotte Hyveled | Director | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | ||
TriSalus Life Sciences Inc | Liselotte Hyveled | Director | 06 May 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |